Pyrrolopyrimidines for pharmaceutical compositions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8697713
APP PUB NO 20100105708A1
SERIAL NO

12373224

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel pyrrolopyrimidine compounds of the general formula (1) and pharmaceutical compositions comprising said pyrrolopyrimidine compounds. Moreover, the present invention relates to the use of the pyrrolopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EVOTEC INTERNATIONAL GMBHESSENER BOGEN 7 22419 HAMBURG 22419

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Coulter, Thomas Stephen Wantage, GB 17 172
Jäkel, Stefan Darmstadt, DE 5 23
Murfin, Stephen Didcot, GB 4 72
Reuter, Tanja Darmstadt, DE 3 44
Taylor, Steven Didcot, GB 55 1098

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 15, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00